This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Posttraumatic Stress Disorder
and you are
between 18 and 65
years old
Phase
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The specific aims of this study are: 1. To compare the effectiveness of a cognitive behavioral therapy (prolonged exposure, PE) to that of PE and medication (sertraline). 2. To compare the durability of PE gains to that of PE and sertraline at 3, 6, and 9 months post-treatment. 3. To compare those who have chosen their treatment to those who have not in terms of completion of treatment, treatment satisfaction, and short- and long-term effectiveness of the treatment. 4. To examine cost effectiveness of treatment delivery to trauma survivors with PTSD.

Provided treatments

  • Behavioral: Prolonged exposure (PE)
  • Other: PE plus Sertraline
Tris trial is registered with FDA with number: NCT01600456. The sponsor of the trial is Case Western Reserve University and it is looking for 150 volunteers for the current phase.
Official trial title:
Optimizing PTSD Treatment: PE Versus PE Plus Sertraline